Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lowy

Showing results (321-330 of 401) with videos related to

Pageof 41
Sort By:
The New England Journal of Medicine|August 14, 2020
The Effect of Advances in Lung-Cancer Treatment on Population MortalityNadia Howlader, Gonçalo Forjaz, Meghan J Mooradian, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2022
Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumorsNicolas Çuburu, Lukasz Bialkowski, Sergio M Pontejo, et al.
Vaccine|January 19, 2011
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protectionTroy J Kemp, Allan Hildesheim, Mahboobeh Safaeian, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2011
In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy systemMakoto Mitsunaga, Nobuyuki Kosaka, Rhonda C Kines, et al.
Journal of the National Cancer Institute|October 16, 1996
Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, ChinaC Han, G Qiao, N L Hubbert, et al.
Vaccine|November 6, 2012
Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®)Troy J Kemp, Mahboobeh Safaeian, Allan Hildesheim, et al.
Vaccines|May 25, 2024
Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of VaccinationJimmie L Bullock, Thomas E Hickey, Troy J Kemp, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activitiesXiaolan Qian, Guorong Li, Holly K Asmussen, et al.
Nature|November 11, 1982
Mechanism of activation of a human oncogeneC J Tabin, S M Bradley, C I Bargmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipientsAlfonso J García-Piñeres, Allan Hildesheim, Lori Dodd, et al.
Pageof 41

Showing results (321-330 of 401) with videos related to

Sort By:
Pageof 41
The New England Journal of Medicine|August 14, 2020
The Effect of Advances in Lung-Cancer Treatment on Population MortalityNadia Howlader, Gonçalo Forjaz, Meghan J Mooradian, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2022
Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumorsNicolas Çuburu, Lukasz Bialkowski, Sergio M Pontejo, et al.
Vaccine|January 19, 2011
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protectionTroy J Kemp, Allan Hildesheim, Mahboobeh Safaeian, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2011
In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy systemMakoto Mitsunaga, Nobuyuki Kosaka, Rhonda C Kines, et al.
Journal of the National Cancer Institute|October 16, 1996
Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, ChinaC Han, G Qiao, N L Hubbert, et al.
Vaccine|November 6, 2012
Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®)Troy J Kemp, Mahboobeh Safaeian, Allan Hildesheim, et al.
Vaccines|May 25, 2024
Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of VaccinationJimmie L Bullock, Thomas E Hickey, Troy J Kemp, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activitiesXiaolan Qian, Guorong Li, Holly K Asmussen, et al.
Nature|November 11, 1982
Mechanism of activation of a human oncogeneC J Tabin, S M Bradley, C I Bargmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipientsAlfonso J García-Piñeres, Allan Hildesheim, Lori Dodd, et al.
Pageof 41